1-(4-{(1R)-1-[2-({6-[1-(Cyclopropylmethyl)-1H-pyrazol-4-yl]-1H-benzimidazol-2-yl}amino)pyridin-4-yl]ethyl}piperazin-1-yl)-3,3,3-trifluoropropan-1-one (Compound)

Pubchem:PUBCHEM:145714274

Id:9da5047a-751f-5ed4-9f81-526250255a2b

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View 1-(4-{(1R)-1-[2-({6-[1-(Cyclopropylmethyl)-1H-pyrazol-4-yl]-1H-benzimidazol-2-yl}amino)pyridin-4-yl]ethyl}piperazin-1-yl)-3,3,3-trifluoropropan-1-one's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for 1-(4-{(1R)-1-[2-({6-[1-(Cyclopropylmethyl)-1H-pyrazol-4-yl]-1H-benzimidazol-2-yl}amino)pyridin-4-yl]ethyl}piperazin-1-yl)-3,3,3-trifluoropropan-1-one.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with 1-(4-{(1R)-1-[2-({6-[1-(Cyclopropylmethyl)-1H-pyrazol-4-yl]-1H-benzimidazol-2-yl}amino)pyridin-4-yl]ethyl}piperazin-1-yl)-3,3,3-trifluoropropan-1-one.

Results found

Linked to

	Label	Description
	1-(4-{(1R)-1-[2-({6-[1-(Cyclopropylmethyl)-1H-pyrazol-4-yl]-1H-benzimidazol-2-yl}amino)pyridin-4-yl]ethyl}piperazin-1-yl)-3,3,3-trifluoropropan-1-one bioactivity Receptor-type tyrosine-protein kinase FLT3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	1-(4-{(1R)-1-[2-({6-[1-(Cyclopropylmethyl)-1H-pyrazol-4-yl]-1H-benzimidazol-2-yl}amino)pyridin-4-yl]ethyl}piperazin-1-yl)-3,3,3-trifluoropropan-1-one bioactivity Inhibitor of nuclear factor kappa-B kinase subunit epsilon Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	1-(4-{(1R)-1-[2-({6-[1-(Cyclopropylmethyl)-1H-pyrazol-4-yl]-1H-benzimidazol-2-yl}amino)pyridin-4-yl]ethyl}piperazin-1-yl)-3,3,3-trifluoropropan-1-one bioactivity Serine/threonine-protein kinase 17A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	1-(4-{(1R)-1-[2-({6-[1-(Cyclopropylmethyl)-1H-pyrazol-4-yl]-1H-benzimidazol-2-yl}amino)pyridin-4-yl]ethyl}piperazin-1-yl)-3,3,3-trifluoropropan-1-one bioactivity Serine/threonine-protein kinase ULK1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	1-(4-{(1R)-1-[2-({6-[1-(Cyclopropylmethyl)-1H-pyrazol-4-yl]-1H-benzimidazol-2-yl}amino)pyridin-4-yl]ethyl}piperazin-1-yl)-3,3,3-trifluoropropan-1-one bioactivity Serine/threonine-protein kinase TBK1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

1-(4-{(1R)-1-[2-({6-[1-(Cyclopropylmethyl)-1H-pyrazol-4-yl]-1H-benzimidazol-2-yl}amino)pyridin-4-yl]ethyl}piperazin-1-yl)-3,3,3-trifluoropropan-1-one bioactivity Receptor-type tyrosine-protein kinase FLT3

Knowledge Graph Assertion (Entity type)